A novel naproxen derivative capable of displaying anti-cancer and anti-migratory properties against human breast cancer cells View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-08-07

AUTHORS

Jolly Deb, Joydeb Majumder, Sankar Bhattacharyya, Siddhartha Sankar Jana

ABSTRACT

BACKGROUND: Increasingly, the role of chronic inflammation and its mediators in tumor generation and progression is gaining importance in the field of cancer research. In this context, candidature of non steroidal anti-inflammatory drugs (NSAIDs) as potential anti-tumor therapeutic agent is being evaluated globally. In the present study we have evaluated the anti-cancer effect of a series of newly synthesized naproxen derivatives on human breast cancer cell lines. METHODS: MCF-7 (poorly invasive) and MDA-MB-231 (highly invasive) cells were treated with different concentrations of naproxen sodium and its derivatives in vitro, and the underlying mechanism of action was monitored by employing studies related to induction of apoptosis, activation of caspases, cell-cycle progression, synthesis of PGE2 and cellular migration. RESULTS: After a preliminary screening using MCF-7 and MDA-MB-231 cells, it was evident that naproxen derivative 4 has a better killing property compared to its parent compound naproxen sodium (NS). On further investigation, it was apparent that the observed growth inhibitory activity on MDA-MB-231 cells after treatment with 4, was not due to cell cycle arrest but due to an early induction of apoptosis and subsequent induction of caspases 3 and 9. Derivative 4 could also inhibit COX activity in MDA-MB-231 cells as evidenced by reduction in prostaglandin E2 secretion. Moreover, 4 was capable of delaying the overall migration rate of MDA-MB-231 cells in vitro. CONCLUSION: In this study we report that a naproxen-derivative (4) has powerful anti-inflammatory and anti-tumor properties as it induces appreciable amount of apoptosis in breast cancer cell line, and can also delay migration of cancer cells (MDA-MB-231) which would in turn delay cancer cell invasion and formation of secondary tumours in primary breast cancer patients. Thus, we propose that 4 is worthy of further investigation due to its potential as a therapeutic agent in anti-tumor treatment regimen. More... »

PAGES

567

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1471-2407-14-567

DOI

http://dx.doi.org/10.1186/1471-2407-14-567

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1046119328

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25098498


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Inflammatory Agents, Non-Steroidal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Movement", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Proliferation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "MCF-7 Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Naproxen", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Biological Chemistry, Indian Association for the Cultivation of Science, 2A & 2B Raja S. C. Mullick Road, 700032 Kolkata, India", 
          "id": "http://www.grid.ac/institutes/grid.417929.0", 
          "name": [
            "Department of Biological Chemistry, Indian Association for the Cultivation of Science, 2A & 2B Raja S. C. Mullick Road, 700032 Kolkata, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Deb", 
        "givenName": "Jolly", 
        "id": "sg:person.01176335111.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176335111.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Organic Chemistry, Indian Association for the Cultivation of Science, 2A & 2B Raja S. C. Mullick Road, 700032 Kolkata, India", 
          "id": "http://www.grid.ac/institutes/grid.417929.0", 
          "name": [
            "Department of Organic Chemistry, Indian Association for the Cultivation of Science, 2A & 2B Raja S. C. Mullick Road, 700032 Kolkata, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Majumder", 
        "givenName": "Joydeb", 
        "id": "sg:person.013215317377.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013215317377.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Zoology, Sidho Kanho Birsha University, Purulia, India", 
          "id": "http://www.grid.ac/institutes/grid.440737.3", 
          "name": [
            "Department of Zoology, Sidho Kanho Birsha University, Purulia, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bhattacharyya", 
        "givenName": "Sankar", 
        "id": "sg:person.0621543572.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621543572.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biological Chemistry, Indian Association for the Cultivation of Science, 2A & 2B Raja S. C. Mullick Road, 700032 Kolkata, India", 
          "id": "http://www.grid.ac/institutes/grid.417929.0", 
          "name": [
            "Department of Biological Chemistry, Indian Association for the Cultivation of Science, 2A & 2B Raja S. C. Mullick Road, 700032 Kolkata, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jana", 
        "givenName": "Siddhartha Sankar", 
        "id": "sg:person.01234400514.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234400514.57"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/bcr1019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027953579", 
          "https://doi.org/10.1186/bcr1019"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0997-1034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027964878", 
          "https://doi.org/10.1038/nm0997-1034"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35037710", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003551467", 
          "https://doi.org/10.1038/35037710"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/cddis.2013.179", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015130072", 
          "https://doi.org/10.1038/cddis.2013.179"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1203286", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022281051", 
          "https://doi.org/10.1038/sj.onc.1203286"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00281-012-0342-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028998531", 
          "https://doi.org/10.1007/s00281-012-0342-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-61779-207-6_2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036940040", 
          "https://doi.org/10.1007/978-1-61779-207-6_2"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-08-07", 
    "datePublishedReg": "2014-08-07", 
    "description": "BACKGROUND: Increasingly, the role of chronic inflammation and its mediators in tumor generation and progression is gaining importance in the field of cancer research. In this context, candidature of non steroidal anti-inflammatory drugs (NSAIDs) as potential anti-tumor therapeutic agent is being evaluated globally. In the present study we have evaluated the anti-cancer effect of a series of newly synthesized naproxen derivatives on human breast cancer cell lines.\nMETHODS: MCF-7 (poorly invasive) and MDA-MB-231 (highly invasive) cells were treated with different concentrations of naproxen sodium and its derivatives in vitro, and the underlying mechanism of action was monitored by employing studies related to induction of apoptosis, activation of caspases, cell-cycle progression, synthesis of PGE2 and cellular migration.\nRESULTS: After a preliminary screening using MCF-7 and MDA-MB-231 cells, it was evident that naproxen derivative 4 has a better killing property compared to its parent compound naproxen sodium (NS). On further investigation, it was apparent that the observed growth inhibitory activity on MDA-MB-231 cells after treatment with 4, was not due to cell cycle arrest but due to an early induction of apoptosis and subsequent induction of caspases 3 and 9. Derivative 4 could also inhibit COX activity in MDA-MB-231 cells as evidenced by reduction in prostaglandin E2 secretion. Moreover, 4 was capable of delaying the overall migration rate of MDA-MB-231 cells in vitro.\nCONCLUSION: In this study we report that a naproxen-derivative (4) has powerful anti-inflammatory and anti-tumor properties as it induces appreciable amount of apoptosis in breast cancer cell line, and can also delay migration of cancer cells (MDA-MB-231) which would in turn delay cancer cell invasion and formation of secondary tumours in primary breast cancer patients. Thus, we propose that 4 is worthy of further investigation due to its potential as a therapeutic agent in anti-tumor treatment regimen.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1471-2407-14-567", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "keywords": [
      "MDA-MB-231 cells", 
      "non-steroidal anti-inflammatory drugs", 
      "breast cancer cell lines", 
      "cancer cell lines", 
      "naproxen sodium", 
      "primary breast cancer patients", 
      "therapeutic agents", 
      "steroidal anti-inflammatory drugs", 
      "cancer cells", 
      "human breast cancer cell lines", 
      "breast cancer patients", 
      "prostaglandin E2 secretion", 
      "anti-tumor therapeutic agent", 
      "human breast cancer cells", 
      "anti-inflammatory drugs", 
      "observed growth inhibitory activity", 
      "MCF-7", 
      "anti-cancer effects", 
      "synthesis of PGE2", 
      "cell lines", 
      "breast cancer cells", 
      "anti-tumor properties", 
      "naproxen derivatives", 
      "further investigation", 
      "cancer cell invasion", 
      "treatment regimen", 
      "E2 secretion", 
      "chronic inflammation", 
      "anti-migratory properties", 
      "cancer patients", 
      "cell cycle arrest", 
      "secondary tumors", 
      "induction of apoptosis", 
      "growth inhibitory activity", 
      "COX activity", 
      "tumor generation", 
      "cell cycle progression", 
      "subsequent induction", 
      "cell invasion", 
      "early induction", 
      "cycle arrest", 
      "caspase-3", 
      "underlying mechanism", 
      "cancer research", 
      "cellular migration", 
      "activation of caspases", 
      "inhibitory activity", 
      "apoptosis", 
      "progression", 
      "present study", 
      "induction", 
      "cells", 
      "regimen", 
      "inflammation", 
      "patients", 
      "PGE2", 
      "agents", 
      "tumors", 
      "sodium", 
      "preliminary screening", 
      "secretion", 
      "study", 
      "drugs", 
      "treatment", 
      "mediators", 
      "arrest", 
      "activity", 
      "invasion", 
      "activation", 
      "different concentrations", 
      "screening", 
      "migration", 
      "overall migration rate", 
      "derivatives 4", 
      "caspases", 
      "lines", 
      "role", 
      "action", 
      "rate", 
      "investigation", 
      "reduction", 
      "appreciable amounts", 
      "effect", 
      "concentration", 
      "mechanism", 
      "derivatives", 
      "migration rate", 
      "potential", 
      "importance", 
      "series", 
      "amount", 
      "research", 
      "synthesis", 
      "formation", 
      "generation", 
      "candidature", 
      "context", 
      "properties", 
      "field", 
      "potential anti-tumor therapeutic agent", 
      "naproxen derivative 4", 
      "parent compound naproxen sodium", 
      "compound naproxen sodium", 
      "turn delay cancer cell invasion", 
      "delay cancer cell invasion", 
      "anti-tumor treatment regimen", 
      "novel naproxen derivative"
    ], 
    "name": "A novel naproxen derivative capable of displaying anti-cancer and anti-migratory properties against human breast cancer cells", 
    "pagination": "567", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1046119328"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1471-2407-14-567"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25098498"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1471-2407-14-567", 
      "https://app.dimensions.ai/details/publication/pub.1046119328"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:34", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_645.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1471-2407-14-567"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-14-567'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-14-567'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-14-567'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-14-567'


 

This table displays all metadata directly associated to this object as RDF triples.

270 TRIPLES      22 PREDICATES      152 URIs      137 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1471-2407-14-567 schema:about N0273341885d6468089b0c84ce4e24832
2 N17e0a2fddab546b3819203e94d8c9662
3 N3b048405acc34be0bb321b450a4d70ec
4 N524b87728b1c4470a8a3a41a4ea2032a
5 N6114f0a20b9f4a00a28eab7d1619838c
6 N6cd027675b3b4cf2a1ad621f6b56c95c
7 N75e67c9175c8433cac334cf0aaa085e6
8 N8dc66cdc955149c2ad483486492ca126
9 N9417c9f7feb841b08cf84fd0eeaf70ee
10 Nd30aa00798ac480e87497ac44240a0b9
11 Ne3f3bd5767aa4fd2bcd1fb8509e07fb2
12 Nfa65c4999c964a4bbf3ea9ab074ed858
13 anzsrc-for:11
14 anzsrc-for:1112
15 schema:author N85c74f910eee4ce9bac6082bf4d960b9
16 schema:citation sg:pub.10.1007/978-1-61779-207-6_2
17 sg:pub.10.1007/s00281-012-0342-8
18 sg:pub.10.1038/35037710
19 sg:pub.10.1038/cddis.2013.179
20 sg:pub.10.1038/nm0997-1034
21 sg:pub.10.1038/sj.onc.1203286
22 sg:pub.10.1186/bcr1019
23 schema:datePublished 2014-08-07
24 schema:datePublishedReg 2014-08-07
25 schema:description BACKGROUND: Increasingly, the role of chronic inflammation and its mediators in tumor generation and progression is gaining importance in the field of cancer research. In this context, candidature of non steroidal anti-inflammatory drugs (NSAIDs) as potential anti-tumor therapeutic agent is being evaluated globally. In the present study we have evaluated the anti-cancer effect of a series of newly synthesized naproxen derivatives on human breast cancer cell lines. METHODS: MCF-7 (poorly invasive) and MDA-MB-231 (highly invasive) cells were treated with different concentrations of naproxen sodium and its derivatives in vitro, and the underlying mechanism of action was monitored by employing studies related to induction of apoptosis, activation of caspases, cell-cycle progression, synthesis of PGE2 and cellular migration. RESULTS: After a preliminary screening using MCF-7 and MDA-MB-231 cells, it was evident that naproxen derivative 4 has a better killing property compared to its parent compound naproxen sodium (NS). On further investigation, it was apparent that the observed growth inhibitory activity on MDA-MB-231 cells after treatment with 4, was not due to cell cycle arrest but due to an early induction of apoptosis and subsequent induction of caspases 3 and 9. Derivative 4 could also inhibit COX activity in MDA-MB-231 cells as evidenced by reduction in prostaglandin E2 secretion. Moreover, 4 was capable of delaying the overall migration rate of MDA-MB-231 cells in vitro. CONCLUSION: In this study we report that a naproxen-derivative (4) has powerful anti-inflammatory and anti-tumor properties as it induces appreciable amount of apoptosis in breast cancer cell line, and can also delay migration of cancer cells (MDA-MB-231) which would in turn delay cancer cell invasion and formation of secondary tumours in primary breast cancer patients. Thus, we propose that 4 is worthy of further investigation due to its potential as a therapeutic agent in anti-tumor treatment regimen.
26 schema:genre article
27 schema:inLanguage en
28 schema:isAccessibleForFree true
29 schema:isPartOf N2ed0675bfbf34701aa27da0dc9b9c38b
30 Nea6ff1b5e0e142bfa92980cdbf846ff1
31 sg:journal.1024632
32 schema:keywords COX activity
33 E2 secretion
34 MCF-7
35 MDA-MB-231 cells
36 PGE2
37 action
38 activation
39 activation of caspases
40 activity
41 agents
42 amount
43 anti-cancer effects
44 anti-inflammatory drugs
45 anti-migratory properties
46 anti-tumor properties
47 anti-tumor therapeutic agent
48 anti-tumor treatment regimen
49 apoptosis
50 appreciable amounts
51 arrest
52 breast cancer cell lines
53 breast cancer cells
54 breast cancer patients
55 cancer cell invasion
56 cancer cell lines
57 cancer cells
58 cancer patients
59 cancer research
60 candidature
61 caspase-3
62 caspases
63 cell cycle arrest
64 cell cycle progression
65 cell invasion
66 cell lines
67 cells
68 cellular migration
69 chronic inflammation
70 compound naproxen sodium
71 concentration
72 context
73 cycle arrest
74 delay cancer cell invasion
75 derivatives
76 derivatives 4
77 different concentrations
78 drugs
79 early induction
80 effect
81 field
82 formation
83 further investigation
84 generation
85 growth inhibitory activity
86 human breast cancer cell lines
87 human breast cancer cells
88 importance
89 induction
90 induction of apoptosis
91 inflammation
92 inhibitory activity
93 invasion
94 investigation
95 lines
96 mechanism
97 mediators
98 migration
99 migration rate
100 naproxen derivative 4
101 naproxen derivatives
102 naproxen sodium
103 non-steroidal anti-inflammatory drugs
104 novel naproxen derivative
105 observed growth inhibitory activity
106 overall migration rate
107 parent compound naproxen sodium
108 patients
109 potential
110 potential anti-tumor therapeutic agent
111 preliminary screening
112 present study
113 primary breast cancer patients
114 progression
115 properties
116 prostaglandin E2 secretion
117 rate
118 reduction
119 regimen
120 research
121 role
122 screening
123 secondary tumors
124 secretion
125 series
126 sodium
127 steroidal anti-inflammatory drugs
128 study
129 subsequent induction
130 synthesis
131 synthesis of PGE2
132 therapeutic agents
133 treatment
134 treatment regimen
135 tumor generation
136 tumors
137 turn delay cancer cell invasion
138 underlying mechanism
139 schema:name A novel naproxen derivative capable of displaying anti-cancer and anti-migratory properties against human breast cancer cells
140 schema:pagination 567
141 schema:productId N1d36e12070ee4dd39316784ce67f8481
142 N50522c4b28f942c1af22efd249ecc455
143 N6bb98d66c7c647aebd3888e75c496a6b
144 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046119328
145 https://doi.org/10.1186/1471-2407-14-567
146 schema:sdDatePublished 2022-01-01T18:34
147 schema:sdLicense https://scigraph.springernature.com/explorer/license/
148 schema:sdPublisher Ndb4f6ec301d64ba687120e25a8b46fe9
149 schema:url https://doi.org/10.1186/1471-2407-14-567
150 sgo:license sg:explorer/license/
151 sgo:sdDataset articles
152 rdf:type schema:ScholarlyArticle
153 N0273341885d6468089b0c84ce4e24832 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Female
155 rdf:type schema:DefinedTerm
156 N17e0a2fddab546b3819203e94d8c9662 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Anti-Inflammatory Agents, Non-Steroidal
158 rdf:type schema:DefinedTerm
159 N1d36e12070ee4dd39316784ce67f8481 schema:name dimensions_id
160 schema:value pub.1046119328
161 rdf:type schema:PropertyValue
162 N1ff24f6a50d34ef9bd7166c2d085b055 rdf:first sg:person.01234400514.57
163 rdf:rest rdf:nil
164 N2ed0675bfbf34701aa27da0dc9b9c38b schema:volumeNumber 14
165 rdf:type schema:PublicationVolume
166 N32e9dba526664a8aaed00e06a0103d08 rdf:first sg:person.013215317377.71
167 rdf:rest N964eeffa1c9748a3b5d62b12745ede23
168 N3b048405acc34be0bb321b450a4d70ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name MCF-7 Cells
170 rdf:type schema:DefinedTerm
171 N50522c4b28f942c1af22efd249ecc455 schema:name pubmed_id
172 schema:value 25098498
173 rdf:type schema:PropertyValue
174 N524b87728b1c4470a8a3a41a4ea2032a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Mice
176 rdf:type schema:DefinedTerm
177 N6114f0a20b9f4a00a28eab7d1619838c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Animals
179 rdf:type schema:DefinedTerm
180 N6bb98d66c7c647aebd3888e75c496a6b schema:name doi
181 schema:value 10.1186/1471-2407-14-567
182 rdf:type schema:PropertyValue
183 N6cd027675b3b4cf2a1ad621f6b56c95c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Cell Movement
185 rdf:type schema:DefinedTerm
186 N75e67c9175c8433cac334cf0aaa085e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Gene Expression Regulation, Neoplastic
188 rdf:type schema:DefinedTerm
189 N85c74f910eee4ce9bac6082bf4d960b9 rdf:first sg:person.01176335111.48
190 rdf:rest N32e9dba526664a8aaed00e06a0103d08
191 N8dc66cdc955149c2ad483486492ca126 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Humans
193 rdf:type schema:DefinedTerm
194 N9417c9f7feb841b08cf84fd0eeaf70ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Cell Line, Tumor
196 rdf:type schema:DefinedTerm
197 N964eeffa1c9748a3b5d62b12745ede23 rdf:first sg:person.0621543572.30
198 rdf:rest N1ff24f6a50d34ef9bd7166c2d085b055
199 Nd30aa00798ac480e87497ac44240a0b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Naproxen
201 rdf:type schema:DefinedTerm
202 Ndb4f6ec301d64ba687120e25a8b46fe9 schema:name Springer Nature - SN SciGraph project
203 rdf:type schema:Organization
204 Ne3f3bd5767aa4fd2bcd1fb8509e07fb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name Cell Proliferation
206 rdf:type schema:DefinedTerm
207 Nea6ff1b5e0e142bfa92980cdbf846ff1 schema:issueNumber 1
208 rdf:type schema:PublicationIssue
209 Nfa65c4999c964a4bbf3ea9ab074ed858 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
210 schema:name Breast Neoplasms
211 rdf:type schema:DefinedTerm
212 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
213 schema:name Medical and Health Sciences
214 rdf:type schema:DefinedTerm
215 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
216 schema:name Oncology and Carcinogenesis
217 rdf:type schema:DefinedTerm
218 sg:journal.1024632 schema:issn 1471-2407
219 schema:name BMC Cancer
220 schema:publisher Springer Nature
221 rdf:type schema:Periodical
222 sg:person.01176335111.48 schema:affiliation grid-institutes:grid.417929.0
223 schema:familyName Deb
224 schema:givenName Jolly
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176335111.48
226 rdf:type schema:Person
227 sg:person.01234400514.57 schema:affiliation grid-institutes:grid.417929.0
228 schema:familyName Jana
229 schema:givenName Siddhartha Sankar
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234400514.57
231 rdf:type schema:Person
232 sg:person.013215317377.71 schema:affiliation grid-institutes:grid.417929.0
233 schema:familyName Majumder
234 schema:givenName Joydeb
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013215317377.71
236 rdf:type schema:Person
237 sg:person.0621543572.30 schema:affiliation grid-institutes:grid.440737.3
238 schema:familyName Bhattacharyya
239 schema:givenName Sankar
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621543572.30
241 rdf:type schema:Person
242 sg:pub.10.1007/978-1-61779-207-6_2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036940040
243 https://doi.org/10.1007/978-1-61779-207-6_2
244 rdf:type schema:CreativeWork
245 sg:pub.10.1007/s00281-012-0342-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028998531
246 https://doi.org/10.1007/s00281-012-0342-8
247 rdf:type schema:CreativeWork
248 sg:pub.10.1038/35037710 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003551467
249 https://doi.org/10.1038/35037710
250 rdf:type schema:CreativeWork
251 sg:pub.10.1038/cddis.2013.179 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015130072
252 https://doi.org/10.1038/cddis.2013.179
253 rdf:type schema:CreativeWork
254 sg:pub.10.1038/nm0997-1034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027964878
255 https://doi.org/10.1038/nm0997-1034
256 rdf:type schema:CreativeWork
257 sg:pub.10.1038/sj.onc.1203286 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022281051
258 https://doi.org/10.1038/sj.onc.1203286
259 rdf:type schema:CreativeWork
260 sg:pub.10.1186/bcr1019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027953579
261 https://doi.org/10.1186/bcr1019
262 rdf:type schema:CreativeWork
263 grid-institutes:grid.417929.0 schema:alternateName Department of Biological Chemistry, Indian Association for the Cultivation of Science, 2A & 2B Raja S. C. Mullick Road, 700032 Kolkata, India
264 Department of Organic Chemistry, Indian Association for the Cultivation of Science, 2A & 2B Raja S. C. Mullick Road, 700032 Kolkata, India
265 schema:name Department of Biological Chemistry, Indian Association for the Cultivation of Science, 2A & 2B Raja S. C. Mullick Road, 700032 Kolkata, India
266 Department of Organic Chemistry, Indian Association for the Cultivation of Science, 2A & 2B Raja S. C. Mullick Road, 700032 Kolkata, India
267 rdf:type schema:Organization
268 grid-institutes:grid.440737.3 schema:alternateName Department of Zoology, Sidho Kanho Birsha University, Purulia, India
269 schema:name Department of Zoology, Sidho Kanho Birsha University, Purulia, India
270 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...